剑桥科技公告，公司发行的6701.05万股境外上市外资股（H股）已于2025年10月28日在香港联交所主板 挂牌并上市交易。根据本次发行方案，公司同意由独家保荐人兼整体协调人于2025年11月10日悉数行使 超额配股权，按最终发售价每股H股68.88港元发行1005.15万股H股股份。超额配股权悉数行使后，本次 发行的H股股份由6701.05万股增加至7706.2万股。 ...

Core Viewpoint - Zijin Mining International (02259.HK) announced the end of the stabilization period for its global offering on October 25, 2025, which is 30 days after the deadline for submitting applications for the Hong Kong public offering [1] Group 1 - The stabilization agent, Morgan Stanley Asia Limited, or its affiliates, undertook stabilization actions during the stabilization period, including the allocation of a total of 52,348,600 shares, which represents approximately 15% of the total shares initially available for subscription under the global offering [1] - The overall coordinator exercised the overallotment option on October 8, 2025, involving 52,348,600 shares at a price of HKD 71.59 per share, which is the offering price excluding various fees [1] - The shares were borrowed by the stabilization agent under a borrowing agreement to facilitate the return of shares to Jinshan Hong Kong [1] Group 2 - During the stabilization period, the stabilization agent did not buy or sell any shares in the market to stabilize the price [2]

香港交易及結算所有限公司、香港聯合交易所有限公司（「聯交所」）及香港中央結算有限公司 （「香港結算」）對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表 示概不會就本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 本公告不得直接或間接於或向美國（包括其領土及屬地、美國任何州以及哥倫比亞特區）或法律 禁止有關派發的任何其他司法管轄區發佈、刊發、派發。本公告並不構成證券的任何出售要約 或招攬買入、購買或認購的要約或其組成部分，亦不得在美國境內或有關要約或招攬屬違法的 任何其他司法管轄區出售任何發售股份。本公告提及的證券並無亦不會根據1933年美國證券法 （經不時修訂）（「美國證券法」）或美國任何州的證券法登記。證券不得在美國境內或向或代表美 國人士（定義見美國證券法S規例（「S規例」））或為其利益而提呈發售、出售、質押或轉讓，惟 根據美國證券法的登記規定可獲豁免或於不受其規限的交易，並遵守任何適用州證券法則另作 別論。證券將不會在美國公開發售。發售股份乃依據美國證券法S規例以離岸交易方式僅在美 國境外提呈發售及出售。 本公告僅作說明用途，並不構成收購、購買或認購本公 ...

Core Insights - The company, Jinfang Pharmaceutical-B (02595), announced that the sole sponsor and overall coordinator has fully exercised the over-allotment option as of October 16, 2025, involving a total of 13.386 million H-shares, which represents approximately 15% of the total shares available for subscription before the exercise of any over-allotment options [1] - The over-allotment shares will be issued at a price of HKD 20.39 per H-share and will be used to cover the excess allocation in the international offering [1] - The stabilization period for the global offering ended on October 16, 2025, which is 30 days after the submission deadline for the Hong Kong public offering application [1]

Group 1 - The major shareholder of Daheng Technology (02543) deposited shares into CITIC Securities (601066) with a market value of HKD 59.2448 million, representing 12.4% of the total [1] - Daheng Technology announced the issuance and allocation of 1.121 million H-shares on October 9, 2025, at an issue price of HKD 49.5 per share due to the exercise of the over-allotment option [1]

Core Viewpoint - Zijin Mining International (02259) has exercised its overall coordinator's over-allotment option, resulting in the issuance of 52.3486 million shares, which represents approximately 15% of the total shares available for subscription before the exercise of the over-allotment option [1] Group 1 - The over-allotment shares will be issued at a price of HKD 71.59 per share [1] - The purpose of the over-allotment shares is to facilitate the return of 52.3486 million shares borrowed by Morgan Stanley Asia Limited or its affiliates under a stock borrowing agreement [1] - This action is intended to support the settlement of the international offering's over-allocation [1]

香港交易及結算所有限公司、香港聯合交易所有限公司（「聯交所」）及香港中央結算有限公司 （「香港結算」）對本公告的內容概不負責，對其準確性或完整性亦不發表聲明，並明確表示概不 會就因本公告全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 本公告不會直接或間接於或向美國（包括其領土及屬地、美國任何州以及哥倫比亞特區）發佈、 刊發或派發。本公告並不構成或組成在美國境內或於任何其他司法管轄區購買或認購任何證券 的任何要約或招攬的一部分。發售股份並無亦不會根據《1933年美國證券法》（經修訂)(「美國證 券法」）或美國任何州或其他司法管轄區的證券法登記。發售股份不得在美國境內提呈發售、出 售、質押或以其他方式轉讓，惟可獲豁免遵守美國證券法登記規定或毋須遵守美國證券法登記 規定的交易除外。發售股份不會在美國公開發售。發售股份僅可根據美國證券法S規例在美國 境外以離岸交易方式提呈發售、出售及交付。 本公告僅作說明用途，並不構成收購、購買或認購證券的邀請或要約。本公告並非招股章程。 潛在投資者於決定是否投資所提呈發售的H股前，應閱覽上海摯達科技發展股份有限公司（「本 公司」）刊發日期為2025年9月30 ...

Group 1 - The announcement states that the stabilization period for the global offering of Aux Group (02580) ended on September 27, 2025, which is 30 days after the deadline for submitting the application for the Hong Kong public offering [1] - The sole sponsor and overall coordinator did not exercise the over-allotment option during the stabilization period, and this option expired on September 27, 2025 [1] - As a result, the company has not and will not issue any shares under the over-allotment option [1]

Core Viewpoint - Hesai Technology (02525) announced that the underwriters and overall coordinators have fully exercised the over-allotment option as of September 16, 2025, involving a total of 2.9325 million shares, which accounts for 15% of the total shares available for subscription in the global offering [1] Group 1 - The over-allotment shares will be issued at a price of HKD 212.80 per share [1] - The over-allotment shares are intended to cover the excess allocation in the international offering [1] - The Hong Kong Stock Exchange has approved the listing and trading of the over-allotment shares, which are expected to commence on September 19, 2025, at 9:00 AM [1]

Core Viewpoint - Jiaxin International Resources (03858) announced the issuance of 16.4712 million ordinary shares due to the full exercise of the over-allotment option on September 2, 2025 [1] Company Summary - The company has exercised its over-allotment option, resulting in the issuance of a significant number of ordinary shares [1]